1 year return (CAGR)
346.02%
Definium Therapeutics, Inc. Exchange (NASDAQ, USD)
DFTX
40.32
+1.04 (+2.65%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
113.04%
5 year return (CAGR)
3.26%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
5.42B
Price/Sales
-
Ent value
4.96B
Price/Book
5.90
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
1.38%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 39.42 |
| Daily high | 40.39 |
| Daily low | 38.70 |
| Daily Volume | 1.75M |
| All-time high | 70.35 |
| 1y analyst estimate | 67.47 |
| Beta | 2.26 |
| EPS (TTM) | -3.20 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 5 Mar 2026 |
Downside potential
Loading...
Downside potential data
| DFTX | S&P500 | |
| Current price drop from All-time high | -42.69% | -0.58% |
| Highest price drop | -99.92% | -56.47% |
| Date of highest drop | 26 Dec 2019 | 9 Mar 2009 |
| Avg drop from high | -74.66% | -10.68% |
| Avg time to new high | 39 days | 12 days |
| Max time to new high | 1359 days | 1805 days |
News
